Pricing Log in Create free account

Corbus Pharmaceuticals Holdings, Inc. (CRBP) vs MAIA Biotechnology, Inc. (MAIA)

Corbus Pharmaceuticals Holdings, Inc. and MAIA Biotechnology, Inc. are both Biotechnology companies. MAIA Biotechnology, Inc. is the larger, with a market value of $64.2M against $55.3M — 1.2× the size. Across the 8 metrics below, Corbus Pharmaceuticals Holdings, Inc. leads on 4 and MAIA Biotechnology, Inc. on 4.

Valuation

Metric CRBP MAIA Biotechnology median
P/E n/m n/m 10.26
P/S 36.05 n/m 9.18
P/B 0.54 3.03 2.05
Price to free cash flow n/m n/m 24.81
EV/EBITDA 0.37 n/m 0.65
EV/Sales (26.17) n/m 8.98
Earnings yield (216.43%) (61.14%) (34.89%)
Free cash flow yield (156.18%) (36.04%) (24.52%)

Profitability

Metric CRBP MAIA Biotechnology median
Gross margin 0.00% — 65.16%
Operating margin 0.00% 0.00% 0.00%
Net margin 0.00% 0.00% 0.00%
Free cash flow margin 0.00% 0.00% 0.00%
Return on equity (95.58%) (218.68%) (50.12%)
Return on assets (80.85%) (136.67%) (45.60%)
Return on invested capital 0.00% 0.00% 0.00%

Growth

Metric CRBP MAIA Biotechnology median
Revenue growth (TTM) (73.69%) — 6.26%
EPS growth (last fiscal year) (60.33%) 33.33% 29.88%
Revenue growth, 5-year CAGR (14.34%) — 9.75%
Net income growth, 5-year CAGR 0.00% 0.00% 0.00%

Health

Metric CRBP MAIA Biotechnology median
Debt to equity 0.00 0.00 0.00
Current ratio 5.71 4.51 4.89
Net debt to EBITDA 1.90 0.36 1.01

Dividend

Metric CRBP MAIA Biotechnology median
Dividend yield — — 0.41%
Payout ratio — — —

Size

Metric CRBP MAIA Biotechnology median
Market cap 55.32m 64.22m 172.11m

Compare with another peer

Any metric, up to five companies and an Excel export Powerpack